Torcetrapib/atorvastatin
Alternative Names: Atorvastatin/torcetrapibLatest Information Update: 27 Jun 2017
At a glance
- Originator Pfizer
- Class Antihyperlipidaemics; Fatty acids; Heptanoic acids; Pyrroles; Quinolines
- Mechanism of Action Cholesterol ester transfer protein inhibitors; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Coronary disorders; Hyperlipidaemia; Hyperlipoproteinaemia type III; Hypertriglyceridaemia; Low HDL cholesterol
Most Recent Events
- 02 Dec 2006 Discontinued - Phase-III for Coronary disorders in Australia (PO)
- 02 Dec 2006 Discontinued - Phase-III for Coronary disorders in Canada (PO)
- 02 Dec 2006 Discontinued - Phase-III for Coronary disorders in Netherlands (PO)